| Literature DB >> 20931308 |
Nienke van Egmond1, Daniel C J De Kam, Jean W M Gardeniers, B Willem Schreurs.
Abstract
BACKGROUND: Loosening of acetabular components often leads to bony defects. Management of extensive acetabular bone loss in hip revision arthroplasty can be a tremendous challenge. QUESTIONS/PURPOSES: We asked whether a reconstruction with impacted bone grafts will provide a durable and pain-free function in extensive acetabular defects. We specifically determined the (1) survival rates with the end point of revision for any reason, aseptic revision, and radiographic loosening; (2) visual analog scale (VAS) pain score, Harris hip score (HHS), and the Oxford Hip Questionnaire score (OHQS); (3) number of repeat revisions; (4) complications; and (5) radiographic loosening, wear, and radiolucencies. PATIENTS AND METHODS: We retrospectively followed 25 patients (27 hips) with extensive acetabular defects. No patient was lost to followup. Two patients died during followup. Minimum followup was 3 years (mean, 8.8 years; range, 3-14.1 years).Entities:
Mesh:
Substances:
Year: 2010 PMID: 20931308 PMCID: PMC3018199 DOI: 10.1007/s11999-010-1618-8
Source DB: PubMed Journal: Clin Orthop Relat Res ISSN: 0009-921X Impact factor: 4.176
Results after acetabular revision surgery using different methods
| Study | Reconstruction method | Number of patients (hips) | Followup (years)* | Defect | Survivorship cup removal for any reason (95% CI) | Clinical outcome* | Number of revisions | Number of complications | Radiographic appearances | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HHS* | Other | Number of radiolucent lines | Other | ||||||||
| Berry et al. [ | Bilobed cup | 38 (38) | 3 (2–5) | AAOS Types I–IV | 90 (79–100) | 1 (2.6%) | 5 (13%) | 2 (5.2%) complete; 24 (63%) incomplete | 2 (5.2%) migration | ||
| Chen et al. [ | Bilobed cup | 38 (41) | 3.4 (2–5.5) | Paprosky Types 2A–3C | Pain less severe in 82% | 2 (5%) | 10 (26%) | 6 (16%) complete; 35 (85%) incomplete | 6 (16%) migration | ||
| DeBoer and Christie [ | Bilobed cup | 18 (18) | 4.5 (3.4–6.9) | AAOS Type III | 91 (80–100) | 0 | 1 (5.6%) | 6 (33%) incomplete | |||
| Abeyta et al. [ | Bilobed cup | 25 (25) | 11 | AAOS Type III | 88% at 11 years | 76.5 (25–91) | 3 (12%) | 3 (12%) | 4 (16%) | ||
| Moskal et al. [ | Bilobed cup | 11 (11) | 6 (5–6.8) | AAOS Type III | 85 (81–90) | 0 | 0 | 0 | |||
| Shinar and Harris [ | Structural graft | 62 (70) | 16.5 (14.1–21.4) | Crowe Types I–IV dysplasia | 65% (55%–75%) at 16.5 years | 75 (29–97) | 25 (36%) | 18 (26%) radiographic loose | |||
| Pollock and Whiteside [ | Structural graft | 20 (20) | Minimum 2 | Noncontained superior weightbearing with anterior column defects | 7 (35%) | 6 (30%) radiographic loose; 6 (30%) migration | |||||
| Jasty and Harris [ | Structural graft | 36 (38) | 5.9 (4–9.1) | Large defect | 82 | 8 (32%) | 22 (50%) | 7 (16%) incomplete | 12 (32%) radiographic loose | ||
| Ito et al. [ | Structural graft, jumbo cup, and/or high hip center | 74 (83) | 9.3 (5–13) | AAOS Types I–III | 94.6% (87%–100%) at 10 years | 81 (46–100) | 4 (5%) | 12 (14%) dislocations; 1 (1.2%) deep infection | 12 (15%) complete; 19 (23%) incomplete | ||
| Garbuz et al. [ | Structural graft and some cases reinforcement ring | 116 (54 Type 1; 29 Type 2A; 33 Type 2B) | 7.1 (5–11) | Paprosky Types 1–2B | 2A: 79.5 (19–73); 2B: 71.2 (52–88)** | Success rate: 2A – 90%; 2B – 76% | − 2A 4 (14%) − 2B 15 (45%) | 2A 4 (14%); 2B 4 (12%) | 6 (21%) incomplete 2A | ||
| Garbuz et al. [ | Structural graft and some cases reinforcement ring | 32 (33) | 7 (5–11) | AAOS Types III–IV | 71 (52–88) Group 1** | Success rate: 55% | 15 (45%) | 4 (12%) | |||
| Kawanabe et al. [ | Reinforcement ring and morselized or bulk grafts | 38 (42) | 8.7 (4.3–12) | AAOS Types II–IV | Morselized: 53% (42.5%–63.5%); bulk: 85% (72.4%–91.6%) (radiographic failure) at 10 years | JOA hip score: 77.3 (65–95) | 2 (5%) | 6 (14%) complete | 4 (9.5%) radiographic loose | ||
| Rosson and Schatzker [ | Reinforcement ring and some cases bone grafts | 81 (81) | 5 (2–10) | AAOS Types I–IV | Muller: 87 (61–100); Burch-Schneider: 81 (56–99) | 5 (6%) | 5 (6.2%) complete; 15 (19%) incomplete | ||||
| Saleh et al. [ | Reinforcement ring and structural graft | 19 (20) | 10.5 (5–16) | Gross Type IV > 50% segmental bone loss anterior and posterior column | 77% at 10.5 years | WOMAC: Function 62 (31–93); Pain 18 (8.1–27.9); Stiffness 4.7 (3.6–5.8) | 3 (15%) | 3 (15%) | 0 | 1 (5%) ring migration | |
| Winter et al. [ | Reinforcement ring and morselized bone graft | 38 (38) | 7.3 (4.2–9.4) | AAOS Types III–IV | 82.6 (58.2–94.9) | 1 (2.6%) | 20 (53%) | ||||
| Zehntner and Ganz [ | Reinforcement ring and allograft | 27 (27) | 7.2 (5.5–10) | AAOS Types I–III | 79.6% at 10 years | 9 (33%) | 12 (44%) migration | ||||
| Dearborn and Harris [ | High hip center | 44 (46) | 10.4 (8.5–12.7) | Stages I–IV | 81 (56–100) | 4 (8.7%) | 18 (39%) | 10 (22%) complete | wear 0.17 mm/year (0.03–0.47 mm/year) | ||
| Kelley [ | High hip center | 22 (23) | 2.9 (2–5) | Substantial superior defects | 78 (45–98) | 0 | 6 (27%) | 1 (4.3%) complete; 7 (30%) incomplete | |||
| Schutzer and Harris [ | High hip center | 51 (56) | 3.3 (2–5.3) | Stages I–IV | 86 (36–100) | 0 | 5 (10%) | 4 (7.1%) complete; 33 (59%) incomplete | |||
| Dearborn and Harris [ | Jumbo cup | 24 (24) | 7 (5–10.3) | AAOS Types I–III | 86 (45–100) | 3 (12.5%) | 5 (21%) recurrent dislocations; 5 (21%) septic failure; 4 (19%) trochanteric nonunion; 4 (19%) remaining | 5 (21%) complete | wear 0.2 mm/year (0.03–0.36 mm/year) | ||
| Hendricks and Harris [ | Jumbo cup | 24 (24) | 13.9 (12.3–16.2) | AAOS Types I–III | 79 (46–98) | UCLA activity scores: 5 (1–6) | 3 (12.5%) | 5 (21%) recurrent dislocations; 5 (21%) septic failure; 4 (19%) trochanteric nonunion; 4 (19%) remaining | 5 (21%) complete | ||
| Patel et al. [ | Jumbo cup | 42 (43) | 10 (6–14) | AAOS Types I–III; Paprosky Types 2A–3A | 83% (SE 0.07) at 13 years | 81 (63–99) | 5 (12%) | 2 (4.7%) | 4 (9.3%) incomplete 2 (4.7%) | 2 (4.7%) radiographic loose | |
| Whaley et al. [ | Jumbo cup | 89 (89) | 7.2 (5–11.3) | AAOS Types I–III; Paprosky Types 1–3B | 93% (85%–100%) at 8 years | 83 | 4 (4.4%) | 18 (20%) | 5 (7%) complete | 2 (3%) radiographic failure | |
| Christie et al. [ | Triflange cup | 76 (78) | 4.4 (2–8.9) | AAOS Types III–IV | 82.1 (59–100) | 0 | 19 (24%) | 3 (12%) incomplete | |||
| Dennis [ | Triflange cup | 24 (24) | 4 (2–6.5) | Paprosky Type 3B | 79 (68–89) | 3 (13%) | 3 (13%) | 3 (13%) radiographic loose | |||
| Nehme et al. [ | Trabecular metal | 16 (16) | 2.7 (2–3.25) | Paprosky Types 2A–3B | 70 (52–92) | 1 (6%) | 4 (25%) incomplete | ||||
| Boscainos et al. [ | Trabecular metal | 14 (14) | 2.7 (0.5–3.8) | AAOS Types I–IV | WOMAC: 33 (18–52) | 0 | 3 (21%) | 4 (29%) incomplete | |||
| van Haaren et al. [ | BIG, cemented cup | 68 (71) | 7.2 (1.6–9.7) | AAOS Types I–IV | 72% (54.4%–80.5%) (aseptic loosening) at 7.2 years | 25 (35%) | Graft incorporation: success group – 34 (66%); failed group – 4 (20%) | ||||
| Palm et al. [ | BIG, uncemented cup | 79 (87) | 9 (7–11) | Gustilo and Pasternak Types II, III, IV | 90.5% (83.4%–97.6%) at 9 years | 85 (34–100) | WOMAC: 70 (22–100) | 7 (8%) | 20 (23%) | 5 (5.7%) complete; 16 (18%) incomplete | 5 (7.2%) radiographic loose |
| Buttaro et al. [ | BIG, mesh, cemented cup | 23 (23) | 3 (1–4.7) | AAOS Type III | 90.8% (68.1%–97.6%) at 3 years | Merle D’Aubigné and Postel: 16.2 | 2 (8.7%) | 2 (8.7%) | 5 (22%) | migration 5.1 mm (2–25) | |
| Schreurs et al. [ | BIG, cemented cup | 37 (42) | 12 (3–21) | AAOS Types I–III | 80% (67%–94%) at 20 years | 89 (60–100) | 8 (19%) | 6 (14%) | 6 (14%) complete; 14 (33%) incomplete | 7 (17%) radiographic loose | |
| Schreurs et al. [ | BIG, cemented cup | 56 (60) | 11.8 (10–15) | AAOS Types II–III | 90% at 11.8 years | 85 (83–100) | 5 (8.3%) | 9 (15%) | 15 (25%) | 4 (6.7%) radiographic loose | |
| Schreurs et al. [ | BIG, cemented cup | 28 (35) | 7.5 (3–14) | AAOS Types II–III | 85.1% (73%–97.1%) at 8 years | 82 (52–97) | 6 (17%) | 4 (11%) | 5 (14%) | 5 (14%) radiographic loose | |
| Current study | BIG, mesh, cemented cup | 25 (27) | 8.8 (3–14.1) | AAOS Types III, IV; Paprosky Types 2B–3B | 88% (74.2%–100%) at 10 years | 71.6 (33–95) | OHQS: 24.9 (12–49) | 3 (11%) | 13 (48%) | 2 (7.4%) | 5 (18.5%) radiographic loose; wear 0.05 mm/year (0–0.15 mm/year) |
* Values are expressed as means, with ranges in parentheses; **Modified Harris hip score; AAOS = American Academy of Orthopaedic Surgeons; BIG = bone impaction grafting; HHS = Harris hip score; JOA = Japanese Orthopaedic Association; SE = standard error; UCLA = University of California at Los Angeles; WOMAC = Western Ontario and McMaster Universities Arthritis Index.
Fig. 1An example of an X-Change large-rim mesh is shown.
Fig. 2A–D(A) A flexible stainless steel mesh is used to close the segmental defects. (B) For acetabular reconstruction, 7- to 10-mm diameter fresh-frozen morselized bone chips are impacted using end metal impactors in several diameters. (C) With a hammer, the bone chips, layer by layer, are compressed tightly. (D) Bone cement is introduced in a relatively viscous state and is pressurized to force bone cement into the graft. Reconstruction of the cup after cup placement at the anatomic level is shown [6]. (Reproduced with permission from Busch VJ, Gardeniers JW, Slooff TJ, Veth RP, Schreurs BW. [Favourable long-term results from cemented total hip arthroplasty combined with acetabular bone impaction grafting in patients under the age of 50] [in Dutch]. Ned Tijdschr Geneeskd. 2007;151:1935–1940.).
Fig. 3A–B(A) An AP radiograph shows the right acetabulum of a patient who had aseptic loosening of two cups in the pelvis with an AAOS Type III and Paprosky Type 3B defect. (B) Twelve years after revision, no radiolucent lines, no migration, and incorporation of the graft can be seen.
Fig. 4A Kaplan-Meier curve shows survival with an end point of revision of the cup for any reason. Dotted lines = 95% CI. At 10 years, the survival rate was 87.6% (95% CI, 74.2%–100%).
Fig. 5A Kaplan-Meier curve shows survival with an end point of revision of the cup for aseptic loosening. Dotted lines = 95% CI. The survival rate was 95.2% (95% CI, 86.0%–100%) at 10 years.
Fig. 6A Kaplan-Meier curve shows survival with an end point of radiographic loosening of the cup. Dotted lines = 95% CI. The survival rate was 77.2% (95% CI, 59.0%–95.4%) at 10 years.
Clinical outcomes
| Score | Number of patients (hips) available | Median | Mean | Range |
|---|---|---|---|---|
| Preoperative HHS | 15 (15) | 51 | 55.3 | 30–95 |
| Postoperative HHS* | 18 (20) | 73.5 | 71.6 | 33–95 |
| Preoperative OHQS | 2 (2) | 26 | 26 | 17–35 |
| Postoperative OHQS* | 17 (19) | 23 | 24.9 | 12–49 |
| Postoperative VAS pain score at rest* | 17 (18) | 0 | 11.7 | 0–80 |
| Postoperative VAS pain score on movement* | 17 (18) | 0 | 14.7 | 0–70 |
* Surviving hips in living patients who did not have a repeat revision; HHS = Harris hip score; OHQS = Oxford Hip Questionnaire Score; VAS = visual analog scale.
Complications
| Complications | Number | Treatment | Outcome |
|---|---|---|---|
| Cup failures | |||
| Unstable cup | 1 | Resection arthroplasty | Resection arthroplasty |
| Septic loosening | 1 | Resection arthroplasty | Resection arthroplasty |
| Aseptic loosening | 1 | Cup rerevision | No additional problems |
| Revision femoral component | |||
| Recurrent dislocation | 1 | Femoral stem rerevision | No additional problems |
| Perioperative unnoticed distal stem perforation of the femoral shaft | 1 | Femoral stem rerevision | No additional problems |
| Perioperative complication | |||
| Periprosthetic fracture | 3 | Open reduction and internal fixation | Stable reconstruction |
| Postoperative complication | |||
| Neurapraxia of peroneal nerve | 1 | Observation | Permanent partial motor paralysis |
| Dislocation hip | 2 | Newport brace | No additional problems |
| Delayed wound healing with effusion | 1 | Observation | No additional problems |
| Early septic loosening | 1 | Observation (owing to patient’s poor medical condition) | |